Lung Cancer News and Research

Latest Lung Cancer News and Research

Antibody-based theranostic agent shows promise for identifying and treating pancreatic tumors

Pancreatic cancer is associated with bleak five-year survival rates and limited treatment options, but new research is offering hope.

13 Jun 2017

Melbourne study offers hope for better lung cancer treatment

A Melbourne study is set to improve treatment options for patients with the second most common type of lung cancer, lung squamous cell carcinoma, a disease for which new anti-cancer drugs are urgently needed.

13 Jun 2017

Scientists create method for mapping genome-wide DNA damage caused by chemical carcinogen

Scientists have known for decades that smoking cigarettes causes DNA damage, which leads to lung cancer. Now, for the first time, UNC School of Medicine scientists created a method for effectively mapping that DNA damage at high resolution across the genome.

13 Jun 2017

New treatment strategy may destroy difficult-to-treat brain tumors

A new strategy for treating brain tumors may extend or save the lives of patients diagnosed with one of the deadliest forms of cancer, according to a study from UT Southwestern Medical Center.

13 Jun 2017

New biosensor technology could be used in wearable devices to monitor health

Imagine wearing a device that continuously analyzes your sweat or blood for different types of biomarkers, such as proteins that show you may have breast cancer or lung cancer.

13 Jun 2017

Roche to showcase new solutions for lab innovation at EuroMedLab

Roche announced today that it will be showcasing new solutions for lab innovation and leadership at the 22nd IFCC–EFLM European Congress of Clinical Chemistry and Laboratory Medicines in Athens, Greece, 11–15 June.

From Roche Sequencing and Life Science 13 Jun 2017

Emerging blood test could offer effective alternative to detect cancer

Research into a blood test that may spot cancers sooner and allow more targeted treatment is to be presented by a University of Leicester researcher.

12 Jun 2017

Scientists create 'immunoswitch' particles that slow cancer growth in test animals

Scientists at Johns Hopkins have created a nanoparticle that carries two different antibodies capable of simultaneously switching off cancer cells' defensive properties while switching on a robust anticancer immune response in mice.

8 Jun 2017

Customary drug dose for treatment of lung cancer may be higher than needed, study shows

A new study published in the Journal of the National Cancer Institute indicates that the customary pembrolizumab dose for treatment of metastatic non-small cell lung cancer may be higher than is needed for effective treatment.

6 Jun 2017

Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLC

Findings from a phase III clinical trial point to a potential new treatment for patients newly diagnosed with advanced, epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC).

5 Jun 2017

New genomic sequencing approach could be first step toward blood tests for early cancer detection

In a study of 124 patients with advanced breast, lung, and prostate cancers, a new, high-intensity genomic sequencing approach detected circulating tumor DNA at a high rate.

5 Jun 2017

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

Three out of four patients treated with an experimental combination of three different therapies for the rare skin cancer known as Merkel cell carcinoma are in complete remission following the treatment, according to study results from a small clinical trial led at Fred Hutchinson Cancer Research Center.

31 May 2017

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Novartis today announced the US Food and Drug Administration approved the expanded use of Zykadia (ceritinib) to include the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, as detected by an FDA-approved test.

27 May 2017

Some types of cancers are heavily dependent on sugar, study shows

In a new study, scientists at The University of Texas at Dallas have found that some types of cancers have more of a sweet tooth than others.

26 May 2017

FIRS releases new report that outlines global burden of respiratory disease

The Forum of International Respiratory Societies, an organization comprised of the world’s leading international respiratory societies working together to improve lung health globally, today released “The Global Impact of Respiratory Disease.” The report lays out the tremendous impact that respiratory disease has on world health.

26 May 2017

Immunotherapy can be more effective in NSCLC patients who received radiation therapy, study shows

A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.

25 May 2017

NCCN ORP funds researchers to evaluate targeted treatment in EGFRm+ non-small cell lung cancer

The National Comprehensive Cancer Network Oncology Research Program has funded two investigators from NCCN Member Institutions through a collaborative scientific research relationship with AstraZeneca to further evaluate the clinical effectiveness of osimertinib in the treatment of epidermal growth factor receptor-positive (EGFRm+) non-small cell lung cancer (NSCLC).

25 May 2017

Lung Cancer News and Research

Latest Lung Cancer News and Research

Antibody-based theranostic agent shows promise for identifying and treating pancreatic tumors

Melbourne study offers hope for better lung cancer treatment

Scientists create method for mapping genome-wide DNA damage caused by chemical carcinogen

New treatment strategy may destroy difficult-to-treat brain tumors

New biosensor technology could be used in wearable devices to monitor health

Roche to showcase new solutions for lab innovation at EuroMedLab

Emerging blood test could offer effective alternative to detect cancer

Scientists create 'immunoswitch' particles that slow cancer growth in test animals

Customary drug dose for treatment of lung cancer may be higher than needed, study shows

Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLC

New genomic sequencing approach could be first step toward blood tests for early cancer detection

Small clinical trial reveals promising results of triple immunotherapy in treating rare skin cancer

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Some types of cancers are heavily dependent on sugar, study shows

FIRS releases new report that outlines global burden of respiratory disease

Immunotherapy can be more effective in NSCLC patients who received radiation therapy, study shows

NCCN ORP funds researchers to evaluate targeted treatment in EGFRm+ non-small cell lung cancer

Aggressive care in final days of life for advanced cancer patients not linked to better outcomes

BU professor receives Research Innovation and Translation Achievement Award from ATS

Sleep disturbances, long and short duration of sleep may increase risk of dementia and lung cancer

The ultimate guide to lung research tools and protocols eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in